Hypoxia inducible factors in cancer stem cells

por Heddleston, J M, Li, Z, Lathia, J D, Bao, S, Hjelmeland, A B, Rich, J N
Publicado 2010

Hyponatremia as a prognostic and predictive factor in metastatic renal cell carcinoma

por Jeppesen, A N, Jensen, H K, Donskov, F, Marcussen, N, von der Maase, H
Publicado 2010

miR-145 and miR-133a function as tumour suppressors and directly regulate FSCN1 expression in bladder cancer

por Chiyomaru, T, Enokida, H, Tatarano, S, Kawahara, K, Uchida, Y, Nishiyama, K, Fujimura, L, Kikkawa, N, Seki, N, Nakagawa, M
Publicado 2010

In vivo effects of rosiglitazone in a human neuroblastoma xenograft

por Cellai, I, Petrangolini, G, Tortoreto, M, Pratesi, G, Luciani, P, Deledda, C, Benvenuti, S, Ricordati, C, Gelmini, S, Ceni, E, Galli, A, Balzi, M, Faraoni, P, Serio, M, Peri, A
Publicado 2010

p53 mutation, deprivation and poor prognosis in primary breast cancer

por Baker, L, Quinlan, P R, Patten, N, Ashfield, A, Birse-Stewart-Bell, L-J, McCowan, C, Bourdon, J-C, Purdie, C A, Jordan, L B, Dewar, J A, Wu, L, Thompson, A M
Publicado 2010

Reversal of gene expression changes in the colorectal normal-adenoma pathway by NS398 selective COX2 inhibitor

por Galamb, O, Spisák, S, Sipos, F, Tóth, K, Solymosi, N, Wichmann, B, Krenács, T, Valcz, G, Tulassay, Z, Molnár, B
Publicado 2010

Human apurinic/apyrimidinic endonuclease (APE1) is a prognostic factor in ovarian, gastro-oesophageal and pancreatico-biliary cancers

por Al-Attar, A, Gossage, L, Fareed, K R, Shehata, M, Mohammed, M, Zaitoun, A M, Soomro, I, Lobo, D N, Abbotts, R, Chan, S, Madhusudan, S
Publicado 2010

Activating K-Ras mutations outwith ‘hotspot’ codons in sporadic colorectal tumours – implications for personalised cancer medicine

por Smith, G, Bounds, R, Wolf, H, Steele, R J C, Carey, F A, Wolf, C R
Publicado 2010

Co-detection of members of the urokinase plasminogen activator system in tumour tissue and serum correlates with a poor prognosis for soft-tissue sarcoma patients

por Taubert, H, Würl, P, Greither, T, Kappler, M, Bache, M, Lautenschläger, C, Füssel, S, Meye, A, Eckert, A W, Holzhausen, H-J, Magdolen, V, Kotzsch, M
Publicado 2010

Methotrexate area under the curve is an important outcome predictor in patients with primary CNS lymphoma: A pharmacokinetic–pharmacodynamic analysis from the IELSG no. 20 trial

por Joerger, M, Huitema, A D R, Krähenbühl, S, Schellens, J H M, Cerny, T, Reni, M, Zucca, E, Cavalli, F, Ferreri, A J M
Publicado 2010

Early growth response-1 is a regulator of DR5-induced apoptosis in colon cancer cells

por Mahalingam, D, Natoni, A, Keane, M, Samali, A, Szegezdi, E
Publicado 2010

Overexpression of stathmin1 in the diffuse type of gastric cancer and its roles in proliferation and migration of gastric cancer cells

por Jeon, T-Y, Han, M-E, Lee, Y-W, Lee, Y-S, Kim, G-H, Song, G-A, Hur, G-Y, Kim, J-Y, Kim, H-J, Yoon, S, Baek, S-Y, Kim, B-S, Kim, J-B, Oh, S-O
Publicado 2010

The prognostic value of plasma fibrinogen levels in patients with endometrial cancer: a multi-centre trial

por Seebacher, V, Polterauer, S, Grimm, C, Husslein, H, Leipold, H, Hefler-Frischmuth, K, Tempfer, C, Reinthaller, A, Hefler, L
Publicado 2010

High expression of gabarapl1 is associated with a better outcome for patients with lymph node-positive breast cancer

por Berthier, A, Seguin, S, Sasco, A J, Bobin, J Y, De Laroche, G, Datchary, J, Saez, S, Rodriguez-Lafrasse, C, Tolle, F, Fraichard, A, Boyer-Guittaut, M, Jouvenot, M, Delage-Mourroux, R, Descotes, F
Publicado 2010

Identification of DBC1 as a transcriptional repressor for BRCA1

por Hiraike, H, Wada-Hiraike, O, Nakagawa, S, Koyama, S, Miyamoto, Y, Sone, K, Tanikawa, M, Tsuruga, T, Nagasaka, K, Matsumoto, Y, Oda, K, Shoji, K, Fukuhara, H, Saji, S, Nakagawa, K, Kato, S, Yano, T, Taketani, Y
Publicado 2010

Efficacy and tolerability of bevacizumab plus capecitabine as first-line therapy in patients with advanced hepatocellular carcinoma

por Hsu, C-H, Yang, T-S, Hsu, C, Toh, H C, Epstein, R J, Hsiao, L-T, Chen, P-J, Lin, Z-Z, Chao, T-Y, Cheng, A-L
Publicado 2010

Hierarchical clustering of immunohistochemical analysis of the activated ErbB/PI3K/Akt/NF-κB signalling pathway and prognostic significance in prostate cancer

por Koumakpayi, I H, Le Page, C, Mes-Masson, A-M, Saad, F
Publicado 2010

Membrane transport proteins in human melanoma: associations with tumour aggressiveness and metastasis

por Walsh, N, Kennedy, S, Larkin, A M, Tryfonopoulos, D, Eustace, A J, Mahgoub, T, Conway, C, Oglesby, I, Collins, D, Ballot, J, Ooi, W S, Gullo, G, Clynes, M, Crown, J, O'Driscoll, L
Publicado 2010

The effects of adding zoledronic acid to neoadjuvant chemotherapy on tumour response: exploratory evidence for direct anti-tumour activity in breast cancer

por Coleman, R E, Winter, M C, Cameron, D, Bell, R, Dodwell, D, Keane, M M, Gil, M, Ritchie, D, Passos-Coelho, J L, Wheatley, D, Burkinshaw, R, Marshall, S J, Thorpe, H
Publicado 2010

Chemoradiation for the treatment of epidermoid anal cancer: 13-year follow-up of the first randomised UKCCCR Anal Cancer Trial (ACT I)

por Northover, J, Glynne-Jones, R, Sebag-Montefiore, D, James, R, Meadows, H, Wan, S, Jitlal, M, Ledermann, J
Publicado 2010